Kevin Fischbeck
Stock Analyst at B of A Securities
(4.05)
# 469
Out of 5,169 analysts
188
Total ratings
64.39%
Success rate
6.31%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kevin Fischbeck
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OPCH Option Care Health | Maintains: Buy | $32 → $35 | $29.66 | +18.00% | 2 | Dec 9, 2025 | |
| ACHC Acadia Healthcare Company | Downgrades: Underperform | $22 → $13 | $23.20 | -43.97% | 9 | Dec 3, 2025 | |
| ARDT Ardent Health | Maintains: Underperform | $12 → $10 | $9.03 | +10.74% | 4 | Nov 13, 2025 | |
| HUM Humana | Maintains: Neutral | $280 → $300 | $170.42 | +76.04% | 17 | Oct 10, 2025 | |
| ELV Elevance Health | Maintains: Neutral | $330 → $370 | $294.95 | +25.44% | 4 | Oct 10, 2025 | |
| UNH UnitedHealth Group | Maintains: Neutral | $350 → $390 | $284.33 | +37.16% | 27 | Oct 8, 2025 | |
| AMN AMN Healthcare Services | Maintains: Underperform | $20 → $18 | $17.93 | +0.39% | 5 | Sep 10, 2025 | |
| DVA DaVita | Maintains: Underperform | $145 → $140 | $148.83 | -5.93% | 13 | Sep 10, 2025 | |
| THC Tenet Healthcare | Maintains: Buy | $205 → $225 | $203.21 | +10.72% | 8 | Sep 10, 2025 | |
| EHC Encompass Health | Maintains: Buy | $145 → $160 | $99.68 | +60.51% | 2 | Sep 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $52 → $30 | $36.16 | -17.04% | 13 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $215 → $185 | $189.58 | -2.42% | 15 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $394 → $410 | $502.05 | -18.33% | 11 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $3 | $0.59 | +408.39% | 2 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $439 | $148.63 | +195.36% | 15 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $6.5 | $10.47 | -37.92% | 2 | Nov 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $7.25 | $18.19 | -60.14% | 3 | Nov 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $320 → $350 | $264.61 | +32.27% | 6 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $42 → $45 | $12.36 | +264.08% | 7 | Jun 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $7.5 → $5.5 | $3.04 | +80.92% | 10 | Jun 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $35 | $16.25 | +115.38% | 7 | Jan 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $10 | $1.88 | +431.91% | 2 | Jun 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | $7.5 | $8.86 | -15.35% | 1 | Oct 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | n/a | $19.83 | - | 3 | Sep 6, 2019 |
Option Care Health
Dec 9, 2025
Maintains: Buy
Price Target: $32 → $35
Current: $29.66
Upside: +18.00%
Acadia Healthcare Company
Dec 3, 2025
Downgrades: Underperform
Price Target: $22 → $13
Current: $23.20
Upside: -43.97%
Ardent Health
Nov 13, 2025
Maintains: Underperform
Price Target: $12 → $10
Current: $9.03
Upside: +10.74%
Humana
Oct 10, 2025
Maintains: Neutral
Price Target: $280 → $300
Current: $170.42
Upside: +76.04%
Elevance Health
Oct 10, 2025
Maintains: Neutral
Price Target: $330 → $370
Current: $294.95
Upside: +25.44%
UnitedHealth Group
Oct 8, 2025
Maintains: Neutral
Price Target: $350 → $390
Current: $284.33
Upside: +37.16%
AMN Healthcare Services
Sep 10, 2025
Maintains: Underperform
Price Target: $20 → $18
Current: $17.93
Upside: +0.39%
DaVita
Sep 10, 2025
Maintains: Underperform
Price Target: $145 → $140
Current: $148.83
Upside: -5.93%
Tenet Healthcare
Sep 10, 2025
Maintains: Buy
Price Target: $205 → $225
Current: $203.21
Upside: +10.72%
Encompass Health
Sep 10, 2025
Maintains: Buy
Price Target: $145 → $160
Current: $99.68
Upside: +60.51%
Jul 16, 2025
Downgrades: Underperform
Price Target: $52 → $30
Current: $36.16
Upside: -17.04%
Jul 16, 2025
Downgrades: Underperform
Price Target: $215 → $185
Current: $189.58
Upside: -2.42%
Jul 16, 2025
Downgrades: Neutral
Price Target: $394 → $410
Current: $502.05
Upside: -18.33%
Oct 2, 2024
Downgrades: Underperform
Price Target: $3
Current: $0.59
Upside: +408.39%
Apr 1, 2024
Downgrades: Underperform
Price Target: $439
Current: $148.63
Upside: +195.36%
Nov 8, 2023
Downgrades: Underperform
Price Target: $6.5
Current: $10.47
Upside: -37.92%
Nov 2, 2023
Downgrades: Neutral
Price Target: $7.25
Current: $18.19
Upside: -60.14%
Aug 4, 2023
Maintains: Buy
Price Target: $320 → $350
Current: $264.61
Upside: +32.27%
Jun 2, 2023
Upgrades: Buy
Price Target: $42 → $45
Current: $12.36
Upside: +264.08%
Jun 15, 2022
Downgrades: Neutral
Price Target: $7.5 → $5.5
Current: $3.04
Upside: +80.92%
Jan 18, 2022
Maintains: Buy
Price Target: $40 → $35
Current: $16.25
Upside: +115.38%
Jun 10, 2021
Downgrades: Underperform
Price Target: $10
Current: $1.88
Upside: +431.91%
Oct 8, 2020
Initiates: Underperform
Price Target: $7.5
Current: $8.86
Upside: -15.35%
Sep 6, 2019
Downgrades: Underperform
Price Target: n/a
Current: $19.83
Upside: -